Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Medapp SA (MDAP)

Warsaw
Currency in PLN
Disclaimer
0.3240
-0.0010(-0.31%)
Closed
MDAP Scorecard
Fair Value
Unlock Value
Day's Range
0.31000.3240
52 wk Range
0.27000.5800
Bid/Ask
0.315 / 0.324
Prev. Close
0.325
Open
0.317
Day's Range
0.31-0.324
52 wk Range
0.27-0.58
Volume
2,147
Average Volume (3m)
39,049
1-Year Change
9.09%
Shares Outstanding
250,132,454
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about MDAP?
Vote to see community's results!
or

Medapp Company Profile

MedApp S.A. develops solutions to support diagnostic imaging and digital medicine in Poland. The company offers CarnaLife System, an analytical telemedicine system that enables physician to assess and monitor the health of patients and conduct consultations, as well as enable remote measurement, such as pulse oximeter, electrocardiograph, blood pressure monitor, thermometer, scale, auscultation device, and others. It also offers CarnaLife Holo, a 3D imaging system for 3D visualization imaged medical data, which supports the planning and performance of medical procedures; Digital Clinic that offers remote medical care, medical consultations, diagnostics, and in-depth health monitoring; and HoloComm for remote product demonstration in 3D. The company was incorporated in 2010 and is based in Kraków, Poland.

Employees
28
Market
Poland
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.